Blog

Magnus reduced his laryngospasm and respiratory arrest by using IQoro

Magnus Karlsson had long suffered from laryngospasm - cramps in his vocal cords that made it temporarily difficult for him to speak and breathe. He originally bought IQoro to treat acid regurgitation, but it turned out that his breathing problems also improved.
Read Magnus story

IQoro shortlisted for Bionow Product of the Year Award

We are very proud to tell you that IQoro has been shortlisted in the category “Product of the Year” at the prestigious Bionow Awards that will be held in Manchester on March 7, 2024.  The event is a highlight of the life sciences calendar and celebrates the achievements of the sector, showcasing the very best […]

Read more

Jane’s lifelong struggle with acid reflux ended in weeks

Jane had an irritating cough and gunge in the back of her mouth. It interfered when she was speaking and singing, but after several weeks of using IQoro her symptoms are more or less gone.
Read more

A few months with IQoro got Julie off the PPIs

One night about ten years ago her acid reflux suddenly started, always reappearing at bedtime! PPIs and lifestyle changes didn't help. But after a little more than 3 months of treatment with IQoro Julie Lane is once again sound asleep at night.
Read more

MYoroface named one of the fastest growing companies in Europe

MYoroface, the Swedish healthtech company behind the IQoro, has been named one of the fastest growing companies in Europe. The award comes from the annual FT 1000 report developed by The Financial Times, which ranks European companies that have achieved the highest growth in recent years. In the UK, around 13 million people suffer from […]

Read more

Pia stopped being short of breath

For many years, Pia had difficulty climbing stairs. Her hiatus hernia left her short of breath and produced acid reflux. But after nine months of training with IQoro, she got rid of her severe shortness of breath and now copes with stairs without any problems.
Read more

International Reflux Day highlights a serious health problem

More than 20% of the world’s population suffer from reflux and endure symptoms like heartburn, acid reflux and thick phlegm. In many cases, so severely that it is difficult to eat normally – or even to lie down and sleep. To draw attention to this growing, global problem, International Reflux Day has been instituted on […]

Read more

Swedish MedTech company MYoroface expands – innovative medical treatment for reflux now launched across the entire Nordic region

MYoroface is the Swedish MedTech company behind the unique innovation IQoro which treats the underlying cause of acid reflux, heartburn and more. IQoro has now been launched across all Nordic markets. Through a farsighted long-term global expansion strategy, the company wants to eventually address the fifth of the world’s population that suffer from acid reflux. […]

Read more

IQoro meets the new, more rigorous demands for the CE mark

A CE Mark is needed in order to introduce a MedTech product into the EU and currently the UK markets. Starting from 26th May 2021 the new MDR regulations 2017/745 will apply. These set higher demands on suppliers, but what will they mean for consumers? A summary of the new MDR regulations How has MYoroface […]

Read more